AI-guided blood clot removal vs. standard care for brain bleeding
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study compares a new AI-guided procedure to remove blood clots from the brain with standard medical treatment. It may help people who had a stroke from high blood pressure and have a medium-sized bleed in the upper part of the brain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a brain bleed caused by high blood pressure, confirmed on a CT scan.
- The size of the bleed is between 20 and 50 milliliters.
- You are able to open your eyes or follow commands (GCS score of 8 or higher).
- You arrived at the hospital within 24 hours of your symptoms starting.
- You do not have another condition causing the bleed (like a tumor, blood disorder, or aneurysm).
- You do not have a severe head injury, multiple bleeds, or advanced dementia.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a minimally invasive surgery (soft channel drainage) to remove a large blood clot deep in the brain after a stroke. It is for people who can have the procedure within 48 hours of bleeding and whose consciousness is reduced but not completely gone.
This trial uses an AI-assisted ultrasound to quickly detect brain bleeding in people with acute stroke. It may help speed up diagnosis and treatment.
This trial tests a non-invasive ultrasound device to help clear blood clots from the brain after a spontaneous bleed. It may be an option for people with small to medium-sized bleeds who do not need surgery.
This trial tests a minimally invasive robot-guided procedure to remove blood clots that develop after stroke treatment. The goal is to reduce brain damage and improve recovery in patients whose condition got worse after initial stroke therapy.
This trial tests a minimally invasive procedure to remove deep brain bleeds using a special puncture guided by brain imaging, combined with a clot-dissolving drug called tenecteplase. It may help reduce damage from the bleed and improve recovery.
This trial tests a minimally invasive procedure using a special clot-busting medicine (tenecteplase) for a certain type of brain bleed. It aims to see if this approach improves recovery compared to standard care.
Hear when a new Intracerebral Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.